One of the most relevant issues, which todays society face is the use of advanced technologies in the field of GMO and GM-food. Taking a look at the world map of law we can see diverse legal regulation of GMO turnover, especially in the context of regulation and control of genomic studies and their practical application, risk assessment of uncontrollable GMO spreading and technologies of genetic editing of organisms including at the level of research planning. The comparative legal analysis of foreign regulation (including in dominant jurisdictions), provided in this article allows revealing those distinctions, determining the basic tendencies in GMO legal development and connected products with GMO components, including the matters of control with regard to GMO turnover. The analysis allowed drawing several recommendations on borrowing foreign experience for the sake of revising Russian regulation, i.e., taking regulatory measures to develop the relevant sphere of social relationships - legal acts, governmental decrees, etc. oriented towards the development of biotechnologies, raising confidence of citizens in genetics, stimulation of GMO production efficiency, and innovative development. Russia is a member of the Eurasian Economic Union (EAEU); therefore, the article discusses the national laws of these countries concerning GMO and contains recommendations for harmonizing the legal framework of the supranational level in the field of GMO turnover.

In Russia there is currently a great need for high-tech methods of radionuclide diagnostics and therapy. However, given the relatively small number of medical institutions that carry out radionuclide diagnostic and therapeutic methods, the provision of this type of medical care to vulnerable groups of citizens is of particular relevance. The absence of appropriate judicial and legal protection measures in case of failure to provide this type of high-tech assistance is a legislative gap.

The rapid development and achievements of science and technology provides people to improve their lives. Over the past 10 years, genetic researches have grown significantly. Today they are the subject of debate not only by doctors, lawyers, but also theologians. Currently, legislation of countries in Middle East regulates genomics and genetic research differently. Countries are having orient towards religion and therefore pay more attention in these countries to the ethical regulators of Islam besides only legal regulation of genomics (humans, animals, plants, i.e. all living things). Ethical standards are gradually becoming legal norms. In some countries of the Middle East, there are draft laws on the legal regulation of genetics; in some countries given attention in the legal acts of executive authorities in genomics sphere, and in some, have been developed local acts of leading medical centers. A number of eastern countries are also highlighted, in the legislation of which some aspects of the legal regulation of genetic research act as legislative novels. In the most economically developed Middle Eastern countries, genetics is one of the priority programs of the state, in particular, there are national strategic programs for the development of countries already use of modern methods of genome sequencing, bioinformatics, and validation methods. Many Middle Eastern countries have ratified international acts in genetic research and on issues related to their regulation. In addition, Islamic states have developed an independent concept of genomics regulation, taking into account the attitudes of the fundamental sources of Islamic law. Based on the read material of the article, the reader learns about the legal, ethical and legal regulation in the field of genomics of Middle Eastern Islamic states.